These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35743761)

  • 21. Intrathecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG.
    Livrea P; Trojano M; Simone IL; Zimatore GB; Lamontanara G; Leante R
    J Neurol; 1981; 224(3):159-69. PubMed ID: 6162012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breaking Barriers: Unveiling Sex-Related Differences in Cerebrospinal Fluid Analysis-A Narrative Review.
    Candeloro R; Ferri C; Bellini T; Pugliatti M; Castellazzi M
    Biology (Basel); 2024 Jun; 13(6):. PubMed ID: 38927300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
    Senel M; Tumani H; Lauda F; Presslauer S; Mojib-Yezdani R; Otto M; Brettschneider J
    PLoS One; 2014; 9(4):e88680. PubMed ID: 24695382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis.
    Akaishi T; Takahashi T; Fujihara K; Misu T; Nishiyama S; Takai Y; Fujimori J; Abe M; Ishii T; Aoki M; Nakashima I
    Mult Scler Relat Disord; 2020 Oct; 45():102382. PubMed ID: 32674030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of CSF D-Dimer to Identify Intrathecal Fibrin-Driven Autoimmunity in Patients With Multiple Sclerosis.
    Schaller-Paule MA; Yalachkov Y; Steinmetz H; Friedauer L; Hattingen E; Miesbach W; Weber F; Kirchmayr K; Schaefer JH; Foerch C
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of prothrombin fragment 1+2 in cerebrospinal fluid to identify thrombin generation in inflammatory central nervous system diseases.
    Schaefer JH; Yalachkov Y; Friedauer L; Kirchmayr K; Miesbach W; Wenger KJ; Foerch C; Schaller-Paule MA
    Mult Scler Relat Disord; 2022 Apr; 60():103720. PubMed ID: 35294920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intrathecal humoral immune response: laboratory analysis and clinical relevance.
    Sindic CJ; Van Antwerpen MP; Goffette S
    Clin Chem Lab Med; 2001 Apr; 39(4):333-40. PubMed ID: 11388658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannan-binding lectin in cerebrospinal fluid: a leptomeningeal protein.
    Reiber H; Padilla-Docal B; Jensenius JC; Dorta-Contreras AJ
    Fluids Barriers CNS; 2012 Aug; 9(1):17. PubMed ID: 22889364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.
    Pilz G; Sakic I; Wipfler P; Kraus J; Haschke-Becher E; Hitzl W; Trinka E; Harrer A
    Fluids Barriers CNS; 2020 Feb; 17(1):7. PubMed ID: 32089130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier.
    Eickhoff K; Wikström J; Poser S; Bauer H
    J Neurol; 1977 Feb; 214(3):207-15. PubMed ID: 65455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal kappa free light chains as markers for multiple sclerosis.
    Vecchio D; Bellomo G; Serino R; Virgilio E; Lamonaca M; Dianzani U; Cantello R; Comi C; Crespi I
    Sci Rep; 2020 Nov; 10(1):20329. PubMed ID: 33230241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis.
    Liang S; Qin Q; Tang Y; Liao W; Yang Y; He J; Li L
    Ann Palliat Med; 2020 Mar; 9(2):324-330. PubMed ID: 32268769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
    Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
    Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system.
    Kitz K; Lassmann H; Karcher D; Lowenthal A
    Acta Neuropathol; 1984; 63(1):41-50. PubMed ID: 6730912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.
    Reiber H
    J Neurol Sci; 1994 Apr; 122(2):189-203. PubMed ID: 8021703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.